Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

B. Lensberg; M.F. Drummond; N. Danchenko; N. Despiégel; C. François

doi:10.2147/CEOR.S44866

Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

B. Lensberg, M.F. Drummond, N. Danchenko, N. Despiégel, C. François

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Abstract

Lost productivity is often excluded from economic evaluations, which may lead to an underestimation of the societal benefits of treatment. However, there are multiple challenges in reliably estimating and reporting productivity losses. This article explores the main challenges, ie, selecting an appropriate valuation method (ie, human capital, friction cost, or multiplier), avoiding double counting, and accounting for equity. It also discusses the use of presenteeism instruments and their application in clinical trials, with a specific focus on their relevance in individuals with mood disorders. Further research and discussion is required on the development of reliable techniques for measuring and valuing productivity changes due to presenteeism.

Original language	English
Pages (from-to)	565-573
Number of pages	9
Journal	ClinicoEconomics and Outcomes Research
Volume	5
Issue number	1
DOIs	https://doi.org/10.2147/CEOR.S44866
Publication status	Published - 18 Nov 2013

Access to Document

10.2147/CEOR.S44866

Cite this

@article{a247425cd7ec4e1aba54435874bc42a1,

title = "Challenges in measuring and valuing productivity costs, and their relevance in mood disorders",

abstract = "Lost productivity is often excluded from economic evaluations, which may lead to an underestimation of the societal benefits of treatment. However, there are multiple challenges in reliably estimating and reporting productivity losses. This article explores the main challenges, ie, selecting an appropriate valuation method (ie, human capital, friction cost, or multiplier), avoiding double counting, and accounting for equity. It also discusses the use of presenteeism instruments and their application in clinical trials, with a specific focus on their relevance in individuals with mood disorders. Further research and discussion is required on the development of reliable techniques for measuring and valuing productivity changes due to presenteeism.",

author = "B. Lensberg and M.F. Drummond and N. Danchenko and N. Despi{\'e}gel and C. Fran{\c c}ois",

year = "2013",

month = nov,

day = "18",

doi = "10.2147/CEOR.S44866",

language = "English",

volume = "5",

pages = "565--573",

journal = "ClinicoEconomics and Outcomes Research",

issn = "1178-6981",

publisher = "Dove Medical Press Limited",

number = "1",

}

TY - JOUR

T1 - Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

AU - Lensberg, B.

AU - Drummond, M.F.

AU - Danchenko, N.

AU - Despiégel, N.

AU - François, C.

PY - 2013/11/18

Y1 - 2013/11/18

N2 - Lost productivity is often excluded from economic evaluations, which may lead to an underestimation of the societal benefits of treatment. However, there are multiple challenges in reliably estimating and reporting productivity losses. This article explores the main challenges, ie, selecting an appropriate valuation method (ie, human capital, friction cost, or multiplier), avoiding double counting, and accounting for equity. It also discusses the use of presenteeism instruments and their application in clinical trials, with a specific focus on their relevance in individuals with mood disorders. Further research and discussion is required on the development of reliable techniques for measuring and valuing productivity changes due to presenteeism.

AB - Lost productivity is often excluded from economic evaluations, which may lead to an underestimation of the societal benefits of treatment. However, there are multiple challenges in reliably estimating and reporting productivity losses. This article explores the main challenges, ie, selecting an appropriate valuation method (ie, human capital, friction cost, or multiplier), avoiding double counting, and accounting for equity. It also discusses the use of presenteeism instruments and their application in clinical trials, with a specific focus on their relevance in individuals with mood disorders. Further research and discussion is required on the development of reliable techniques for measuring and valuing productivity changes due to presenteeism.

U2 - 10.2147/CEOR.S44866

DO - 10.2147/CEOR.S44866

M3 - Article

SN - 1178-6981

VL - 5

SP - 565

EP - 573

JO - ClinicoEconomics and Outcomes Research

JF - ClinicoEconomics and Outcomes Research

IS - 1

ER -